drugset / Trial / NCT02140528

Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures

NCT02140528

Phase 2 Completed 40 enrolled Royan Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a case-control prospective, clinal trial to assess the safety and efficacy of the allogeneic adipose derived mesenchymal stem cell transplantation on the healing of recent tibial fracture in 40 patients.

Timeline

Start
2013-08
Primary completion
2016-03
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy Other

Indications

No indication recorded.